The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Migita, Kiyoshi ^a   Agematsu, Kazunaga ^b   Masumoto, Junya ^c   Ida, Hiroaki ^d   Honda, Seiyo ^d   Jiuchi, Yuka ^a   Izumi, Yasumori ^a   Maeda, Yumi ^a   Uehara, Ritei ^e   Nakamura, Yoshikazu ^e   Koga, Tomohiro ^f   Kawakami, Atsushi ^f   Nakashima, Munetoshi ^g   Fujieda, Yuichiro ^h   Nonaka, Fumiaki ⁱ   Eguchi, Katsumi ⁱ   Furukawa, Hiroshi ^j   Nakamura, Tadashi ^k   Nakamura, Minoru ^a   Yasunami, Michio ^l  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Nagasaki Red Cross Atomic Bomb Hospital   (Japan)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ Sasebo Shiritsu Sogo Hospital   (Japan)

^j SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^k NTT West Japan Kyushu Hospital   (Japan)

^l NAGASAKI UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; SERUM AMYLOID A;

ADULT; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL 1B GENE; IL 1RA GENE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEFV GENE; SAA1 GENE; SAA2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEMOGRAPHY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; JAPAN; MALE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM AMYLOID A PROTEIN;

EID: 84874263901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055227     Document Type: Article

References (41)

1. Ben-Chetrit E, Levy M, (1998) Familial Mediterranean fever. Lancet 351: 659-64.
2. Chae JJ, Aksentijevich I, Kastner DL, (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146: 467-78.
3. The International FMF Consortium, (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797-807.
4. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, et al. (2009) Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60: 1862-6.
5. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, et al. (2009) Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 60: 1851-61.
6. Franchi L, Warner N, Viani K, Nuñez G, (2009) Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 227: 106-28.
7. Savic S, Dickie LJ, Battellino M, McDermott MF, (2012) Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 24: 103-12.
8. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G, (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-7.
9. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-65.
10. Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, et al. (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186: 6119-28.
11. Marhaug G, Dowton SB, (1994) Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. Baillieres Clin Rheumatol 8: 553-73.
12. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, et al. (2006) Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford) 45: 43-9.
13. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, et al. (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40: 1879-85.
14. Tanaka M, Migita K, Miyashita T, Maeda Y, Nakamura M, et al. (2007) Coexistence of familial Mediterranean fever and Sjögren's syndrome in a Japanese patient. Clin Exp Rheumatol 25: 792.
15. Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, et al. (2006) SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis. Mod Rheumatol 16: 294-9.
16. Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, et al. (2007) Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol 46: 381-6.
17. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, et al. (2001) A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 44: 1266-72.
18. El-Shanti H, Majeed HA, El-Khateeb M, (2006) Familial mediterranean fever in Arabs. Lancet 367: 1016-24.
19. Ting JP, Kastner DL, Hoffman HM, (2006) CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 6: 183-95.
20. Ozen S, (2009) Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum 60: 1575-7.
21. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, et al. (2011) Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1ß activation and severe autoinflammation in mice. Immunity 34: 755-68.
22. Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, et al. (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30: 2014-8.
23. Ozen S, Berdeli A, Türel B, Kutlay S, Yalcinkaya F, et al. (2006) Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 33: 2498-500.
24. Speletas M, Kalala F, Mitroulis I, Papadopoulos V, Merentiti V, et al. (2009) TLR2 and TLR4 polymorphisms in familial Mediterranean fever. Hum Immunol 70: 750-3.
25. Balci-Peynircioglu B, Taskiran ZE, Türel B, Arici M, Bakkaloglu A, et al. (2008) The analysis of interleukin-1 receptor antagonist and interleukin-1beta gene polymorphisms in Turkish FMF patients: do they predispose to secondary amyloidosis? Clin Exp Rheumatol 26: S99-102.
26. Nakamura T, (2011) Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol 29: 850-7.
27. Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, et al. (2003) An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid 10: 7-11.
28. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB, (1998) SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 5: 262-5.
29. Yilmaz E, Balci B, Kutlay S, Ozen S, Ertürk S, et al. (2003) Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr 45: 198-202.
30. Akar N, Hasipek M, Akar E, Ekim M, Yalçinkaya F, et al. (2003) Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 10: 12-6.
31. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Geneviève D, et al. (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67: 1136-43.
32. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, et al. (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48: 1149-55.
33. Bakkaloglu A, Duzova A, Ozen S, Balci B, Besbas N, et al. (2004) Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J Rheumatol 31: 1139-42.
34. Akar N, Hasipek M, Oztürk A, Akar E, Tekin M, (2006) Serum amyloid A1-13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J Nephrol 19: 318-21.
35. Mavragani CP, Yiannakouris N, Zintzaras E, Melistas L, Ritis K, et al. (2007) Analysis of SAA1 gene polymorphisms in the Greek population: rheumatoid arthritis and FMF patients relative to normal controls. Homogeneous distribution and low incidence of AA amyloidosis. Amyloid 14: 271-5.
36. Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, et al. (2005) Relative transcriptional activities of SAA1 promoters polymorphic at position-13(T/C): potential association between increased transcription and amyloidosis. Amyloid 12: 26-32.
37. van der Hilst JC, Yamada T, Op den Camp HJ, van der Meer JW, Drenth JP, et al. (2008) Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology 47: 1651-4.
38. Yakar S, Livneh A, Kaplan B, Pras M, (1995) The molecular basis of reactive amyloidosis. Semin Arthritis Rheum 24: 255-61.
39. Jéru I, Hayrapetyan H, Duquesnoy P, Cochet E, Serre JL, et al. (2009) Involvement of the modifier gene of a human Mendelian disorder in a negative selection process. PLoS One 4: e7676.
40. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, et al. (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48: 1149-55.
41. Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A, (2003) Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30: 308-12.